Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Gossypin is a flavonoid glycoside originally isolated from H. vitifolius that has diverse biological activities.1,2,3,4,5 It inhibits RANKL-induced osteoclastogenesis in RAW 264.7 cells when used at a concentration of 5 µM.1 Gossypin inhibits Aurora B kinase (IC50 = 11.07 µM in a cell-free assay using the human enzyme), as well as Aurora A kinase and p90 ribosomal S6 kinase 2 (RSK2) at 20 µM.2,3 It induces cell cycle arrest at the G2/M phase and apoptosis in HGC-27 gastric cancer cells.3 Gossypin decreases lactate dehydrogenase (LDH) release induced by the glutathione-depleting agent D,L-buthionine (S,R)-sulfoximine (Item No. 23691) in primary rat cortical cells (IC50 = 7.4 µg/ml).4 It reduces acetic acid-induced writhing in mice, an effect that can be reversed by the opioid antagonist naloxone, in a dose-dependent manner.5
WARNING This product is not for human or veterinary use.
1. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-
2. Plant-
3. Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2. Phytother. Res. 33(3), 640-650 (2019).
4. Gossypin protects primary cultured rat cortical cells from oxidative stress-
5. Gossypin-